Progression‐free survival · women with recurrent epithelial ovarian cancer
It is very uncertain whether weekly paclitaxel changes progression‐free survival compared with three‐weekly paclitaxel (very low certainty).
1 finding from 1 review
Neurotoxicity · women with recurrent epithelial ovarian cancer
It is very uncertain whether weekly paclitaxel changes neurotoxicity compared with three‐weekly paclitaxel (very low certainty).
1 finding from 1 review
Neutropenia · women with recurrent epithelial ovarian cancer
Weekly paclitaxel may leads to lower neutropenia compared with three‐weekly paclitaxel (low certainty).
1 finding from 1 review
Alopecia · women with recurrent epithelial ovarian cancer
Weekly paclitaxel may leads to lower alopecia compared with three‐weekly paclitaxel (low certainty).
1 finding from 1 review
50% or greater reduction in seizure frequency · people with drug‐resistant focal epilepsy
Add‐on stiripentol showed no clear difference in ≥ 50% reduction in seizure frequency compared with add‐on placebo (low certainty).
1 finding from 1 review
Seizure freedom · people with drug‐resistant focal epilepsy
Add‐on stiripentol showed no clear difference in seizure freedom compared with add‐on placebo (low certainty).
1 finding from 1 review
≥ 1 adverse effects · people with drug‐resistant focal epilepsy
Add‐on stiripentol may leads to higher ≥ 1 adverse effects compared with add‐on placebo (low certainty).
1 finding from 1 review
Neurological adverse effects · people with drug‐resistant focal epilepsy
Add‐on stiripentol showed no clear difference in neurological adverse effects compared with add‐on placebo (low certainty).
1 finding from 1 review
Gastrointestinal adverse events · people with drug‐resistant focal epilepsy
1 finding from 1 review
Leaving the study early · people with drug‐resistant focal epilepsy
Add‐on stiripentol showed no clear difference in dropouts compared with add‐on placebo (low certainty).
1 finding from 1 review
Quality of life · people with drug‐resistant focal epilepsy
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Any reason · adults and children with focal seizures
1 finding from 1 review
Intervention not reported
Comparison (reference treatment) · adults and children with focal seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Carbamazepine · adults and children with focal seizures
1 finding from 1 review
Intervention not reported
Comparison (reference treatment) · adults and children with focal seizures
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Lamotrigine · adults and children with focal seizures
1 finding from 1 review
Intervention not reported
Comparison (reference treatment) · adults and children with generalised seizures*
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Sodium valproate · adults and children with generalised seizures*
1 finding from 1 review
Intervention not reported
Adverse events · adults and children with focal seizures
1 finding from 1 review
Intervention not reported
Lack of efficacy · adults and children with focal seizures
1 finding from 1 review